Clinical Trial Update: Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of T101 adenovirus injection with nucleoside analogues in chronic hepatitis B patients; current status and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Therapeutic Hepatitis B Adenovirus Injection (T101) (unknown)

Snippet

Sponsor: Tasly Tianjin Biopharmaceutical Co., Ltd. | Conditions: Hepatitis B Virus (HBV) | Phase 2 | Status: UNKNOWN